Form 4: HilleVax Director Patrick Heron Reports Stock Option Grant

Director Patrick J. Heron reports the acquisition of stock options in HilleVax, Inc. pursuant to the company's non-employee director compensation program.

Summary

• Patrick J. Heron, a director of HilleVax, Inc., filed a Form 4 with the SEC.
• The filing reports the grant of stock options to Heron on June 6, 2024.
• Heron acquired 22,500 stock options with an exercise price of $13.75.
• The options vest on the earlier of the first anniversary of the grant date or the next annual meeting of stockholders, contingent upon continued service on the board.
• Following the transaction, Heron directly owns 22,500 derivative securities.

Sentiment

Score: 7

Explanation: The document indicates a standard compensation practice, suggesting stability and alignment of interests. It's a neutral to slightly positive indicator.

Positives

• The grant of stock options aligns the director's interests with those of the shareholders.
• The vesting schedule incentivizes continued service on the board.

Future Outlook

The director's continued service on the board is incentivized by the vesting schedule of the stock options.

Industry Context

Stock option grants are a common form of compensation for directors of publicly traded companies, aligning their interests with shareholders and incentivizing company performance.

Stakeholder Impact

• The stock option grant aligns the director's interests with those of the shareholders, potentially leading to decisions that benefit the company's overall performance.

Key Dates

Keywords

HilleVax, Director, Stock Options, Form 4, Securities, Beneficial Ownership, HLVX